# EDGAR Filing Document

**Accession Number:** 0001601774
**File Stem:** 0001601774-25-000002
**Filing Date:** 2025-8
**Character Count:** 5671
**Document Hash:** 2100c699ea499ba3b405338d3f21085b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001601774-25-000002.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0001601774-25-000002

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250827

**FILED AS OF DATE**: 20250828

**EFFECTIVENESS DATE**: 20250828

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Impresa Management LLC
- **CENTRAL INDEX KEY:** 0001601774

**ORGANIZATION NAME:**
- **EIN:** 464574430
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16240
- **FILM NUMBER:** 251268012

**BUSINESS ADDRESS:**
- **STREET 1:** 255 STATE STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110
- **BUSINESS PHONE:** 617-563-0773

**MAIL ADDRESS:**
- **STREET 1:** 255 STATE STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001601774

**Date of Report:** 08/27/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Impresa Management LLC

**Address:** 255 STATE STREET, BOSTON, MA 02110

**Telephone number:** 617-392-0785

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 08/27/2025

**SEC File Number:** 028-16240

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 549300S4RVL8X7P76R51

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                       | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                 | VOTE CATEGORY                |     SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| BEAM THERAPEUTICS INC                | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      1.13944e+06 |                0 | FOR         |                              1.13944e+06 | FOR                         |  |
| CYTEK THERAPEUTICS INC               | 23285D109 | 06/18/2025     | To approve, on a non-binding, advisory basis, the compensation for named executive officers for the year ended December 31, 2024.                                                                | SECTION 14A SAY-ON-PAY VOTES | 517790           |                0 | FOR         |                         517790           | FOR                         |  |
| NEUMORA THERAPEUTICS INC             | 640979100 | 05/28/2025     | To approve the repricing of certain outstanding stock options that have been granted under the 2020 Equity Incentive Plan (the "2020 Plan") and the 2023 Incentive Award Plan (the "2023 Plan"). | SECTION 14A SAY-ON-PAY VOTES |      3.4871e+06  |                0 | FOR         |                              3.4871e+06  | FOR                         |  |
| VERVE THERAPEUTICS INC               | 92539P101 | 06/05/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 247153           |                0 | FOR         |                         247153           | FOR                         |  |
| ADAPTIMMUNE THERAPEUTICS PLC SPN ADR | 00653A107 | 05/29/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024.                                                   | SECTION 14A SAY-ON-PAY VOTES |      1.57878e+06 |                0 | FOR         |                              1.57878e+06 | FOR                         |  |
| SHIFT4 PAYMENTS INC                  | 82452J109 | 06/13/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   2105           |                0 | ABSTAIN     |                           2105           | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Impresa Management LLC

**By (Signature):** David Guy

**By (Printed Signature):** David Guy

**By (Title):** Chief Compliance Officer

**Date:** 08/27/2025